News & Updates

In healthcare workers, prophylactic therapy with doxycycline plus zinc seems to reduce the risk of contracting SARS-CoV-2 infection, according to a study.

Extended treatment with decitabine is as good as, but safer than, standard induction chemotherapy (IC) in older patients with acute myeloid leukaemia (AML), according to a phase III study presented at EHA 2022.

In patients diagnosed with opioid use disorders, those who received medication-assisted therapy (MAT) prescriptions have a higher risk of cardiac arrhythmia than those who did not, reports a study.

Use of methotrexate (MTX) appears safe and effective as first-line immunomodulator for maintenance therapy in children with Crohn’s disease (CD), suggests a study presented at the 54th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN 2022).

New drug applications approved by US FDA as of 16 - 30 June 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Use of varenicline in a smoking cessation program for patients with type 2 diabetes (T2D) is safe and effective, facilitating long-term abstinence without adverse consequences, according to the results of a trial.